Literature DB >> 23851610

Uptake and patient outcomes of laparoscopic colon and rectal cancer surgery in a publicly funded system and following financial incentives.

Marko Simunovic1, Nancy N Baxter, Rinku Sutradhar, Ning Liu, Margherita Cadeddu, David Urbach.   

Abstract

PURPOSE: To assess patterns of uptake and outcomes of laparoscopic colon and rectal cancer surgery in Ontario, and the potential influence of surgical fee incentives instituted on October 1, 2005.
METHODS: We used Ontario administrative databases from fiscal years 2002 to 2009. Study outcomes were uptake rates of laparoscopic surgery, hospital length of stay, 30-day operative mortality, cancer-specific survival, and overall survival. The main descriptor for multivariable regression models was a 5% increase in rate of laparoscopic colon cancer surgery in the previous year.
RESULTS: The annual rate of laparoscopic colon and rectal cancer surgery, respectively, rose from 8.7 to 38.9% and from 4.8 to 19.6%. The greatest increase in rate of laparoscopic colon surgery occurred shortly after October 1, 2005. For each 5% increase in rate of laparoscopic surgery, the odds of 30-day mortality was 1.0 [95% confidence interval (CI) 0.96-1.01, p = 0.264], the hazard of cancer-specific survival was 1.0 (95% CI 0.97-1.00, p = 0.139), the hazard of overall survival was 1.0 (95% CI 0.98-1.00, p = 0.051), and length of hospital stay was lower (estimate = -0.10, 95% CI -0.14 to -0.06, p < 0.001).
CONCLUSIONS: In Ontario by the year 2009, 39% of colon and 20% of rectal cancer surgery was provided laparoscopically. Increased rates were associated with a minimal decrease in hospital length of stay and no changes in 30-day mortality, cancer-specific survival, or overall survival. Financial incentives were likely responsible for the marked increase in laparoscopic colon cancer surgery observed after October 1, 2005.

Entities:  

Mesh:

Year:  2013        PMID: 23851610     DOI: 10.1245/s10434-013-3123-2

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  6 in total

1.  Do Diagnostic and Procedure Codes Within Population-Based, Administrative Datasets Accurately Identify Patients with Rectal Cancer?

Authors:  Reilly P Musselman; Tara Gomes; Deanna M Rothwell; Rebecca C Auer; Husein Moloo; Robin P Boushey; Carl van Walraven
Journal:  J Gastrointest Surg       Date:  2018-12-03       Impact factor: 3.452

2.  Uptake of elective laparoscopic colectomy for colon cancer in Canada from 2004/05 to 2014/15: a descriptive analysis.

Authors:  C Marius Hoogerboord; Adrian R Levy; Min Hu; Gordon Flowerdew; Geoffrey Porter
Journal:  CMAJ Open       Date:  2018-09-18

3.  A Comparison of Pathologic Outcomes of Open, Laparoscopic, and Robotic Resections for Rectal Cancer Using the ACS-NSQIP Proctectomy-Targeted Database: a Propensity Score Analysis.

Authors:  Richard Garfinkle; Maria Abou-Khalil; Sahir Bhatnagar; Nathalie Wong-Chong; Laurent Azoulay; Nancy Morin; Carol-Ann Vasilevsky; Marylise Boutros
Journal:  J Gastrointest Surg       Date:  2018-09-27       Impact factor: 3.452

4.  Preoperative endoscopy localization error rate in patients with colorectal cancer.

Authors:  Fady Saleh; Thamer Al Abbasi; Michelle Cleghorn; M Carolina Jimenez; Timothy D Jackson; Allan Okrainec; Fayez A Quereshy
Journal:  Surg Endosc       Date:  2014-12-06       Impact factor: 4.584

5.  A comparison of endoscopic localization error rate between operating surgeons and referring endoscopists in colorectal cancer.

Authors:  Arash Azin; Fady Saleh; Michelle Cleghorn; Andrew Yuen; Timothy Jackson; Allan Okrainec; Fayez A Quereshy
Journal:  Surg Endosc       Date:  2016-07-22       Impact factor: 4.584

6.  The Usefulness of Preoperative Colonoscopic Tattooing with Autologous Blood for Localization in Laparoscopic Colorectal Surgery.

Authors:  Ui Do Yeo; Nak Song Sung; Seung Jae Roh; Won Jun Choi; Kyung Ho Song; In Seok Choi; Dae Sung Yoon; Sang Eok Lee; Ju Ik Moon; Seong Uk Kwon; In Eui Bae; Seung Jae Lee
Journal:  J Minim Invasive Surg       Date:  2020-09-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.